Back to mobile site

Deutsche Bank Starts Amgen (AMGN) At Buy, Citing Appealing Risk/Reward

June 18, 2008 4:47 PM EDT Send to a Friend
Deutsche Bank initiates coverage on Amgen (Nasdaq: AMGN) with a Buy rating and $52 price target, saying while the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login